| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Feb―24 |
Innovative Peptide Therapeutics for SARS-CoV-2: Design, Docking, and Functional Analysis |
Samaneh Karimkhanilouei, Saeid Ghorbian, Sanaz Mahmazi, Changiz Ahmadizadeh, Keivan Nedaei |
| 2 |
[GO] |
2024―Dec―15 |
Predictive Insights Into Bioactive Compounds from Streptomyces as Inhibitors of SARS-CoV-2 Mutant Strains by Receptor Binding Domain: Molecular Docking and Dynamics Simulation Approaches |
Hourieh Kalhor, Mohammad Hossein Mokhtarian, Hamzeh Rahimi, Behzad Shahbazi, Reyhaneh Kalhor, Tahereh Komeili Movahed, Hoda Abolhasani |
| 3 |
[GO] |
2024―Nov―05 |
The COVID-19 Pandemic and the Resilience of the Pharmaceutical Supply Chain: Lessons from Past Experiences and Strategies for the Future |
Mohamad Ali Aivazi, Hamid Reza Rasekh, Mohammad Peikanpour, Farzad Peiravian, Sajjad Esmaeili, Leila Zarei |
| 4 |
[GO] |
2024―Feb―28 |
Erratum: Review on Approved and Inprogress COVID-19 Vaccines |
Soraya Shahhosseini |
| 5 |
[GO] |
2023―Oct―11 |
Evaluation of the Relationship Between Serum miR-200b-3p and miR-214-3p Expression Levels with Soluble ACE2 and TMPRSS2 in COVID-19 Patients |
Faezeh Mortazavi, Mohsen Soltanshahi, Gholamhossein Tamaddon |
| 6 |
[GO] |
2023―Sep―10 |
Designing and Expression of Recombinant Chimeric Spike Protein from SARS-CoV-2 in Escherichia coli and Its Immunogenicity Assessment |
Sahar Karimi, Shahram Nazarian, Fattah Sotoodehnejadnematalahi, Roohollah Dorostkar, Jafar Amani |
| 7 |
[GO] |
2023―Aug―26 |
The Efficacy of High-Dose Pulse Therapy vs. Low-Dose Intravenous Methylprednisolone on Severe to Critical COVID-19 Clinical Outcomes: A Randomized Clinical Trial |
Zahra Sahraei, Parnaz Panahi, Kouroush Solhjoukhah, Maryam Mesbah, Siamak Afaghi, Mahdi Amirdosara, et al. (+3) Jamshid Salamzadeh, Farzad Esmaeili Tarki, Ilad Alavi Darazam |
| 8 |
[GO] |
2022―May―29 |
Influenza Vaccine and COVID-19 Pandemic: Could This Vaccine Help Limit the Potential Adverse Consequences of SARS-CoV-2? |
Reza Mosaed, Hossein Fasihi, Amir Norouzi, Vahid Anjomanian, Mohammad Afshar Ardalan, Farshid Alazmani Noodeh, Ali Reza Khoshdel |
| 9 |
[GO] |
2022―May―17 |
A Single-Centered Cohort Study on Favipiravir Safety and Efficacy in Pediatric Patients with COVID-19 |
Sedigheh Rafiei Tabatabaei, Omid Moradi, Abdollah Karimi, Shahnaz Armin, Alireza Fahimzad, Roxana Mansour Ghanaie, et al. (+4) Mahnaz Jamee, Azam Mousavizadeh, Hossein Amini, Bahador Mirrahimi |
| 10 |
[GO] |
2022―May―09 |
A Review of Virus-Like Particle-Based SARS-CoV-2 Vaccines in Clinical Trial Phases |
Mohammad Sharifzadeh, Negar Mottaghi-Dastjerdi, Mohammad Soltany Rezae Raad |
| 11 |
[GO] |
2022―Apr―28 |
National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19 |
Maryam Sadat Mirenayat, Atefeh Abedini, Arda Kiani, Alireza Eslaminejad, Parisa Adimi naghan, Majid Malekmohammad, et al. (+30) Jalal Heshmatnia, Seyed Alireza Nadji, Esmaeil Idani, Reyhaneh Zahiri, Somayeh Lookzadeh, Hakimeh Sheikhzade, Farzaneh Dastan, Mihan Porabdollah Toutkaboni, Mitra Sadat Rezaei, Elham Askari, Payam Tabarsi, Majid Marjani, Afshin Moniri, Seyed Mohammad Reza Hashemian, Behrooz Farzanegan, Zahra Abtahian, Fatemeh Yassari, Nazanin Mansouri, Davood Mansouri, Maryam Vasheghani, Babak Mansourafshar, Mojtaba Mokhber Dezfoli, Salman Soleimani, Sharareh Seifi, Farah Naghashzadeh, Atefeh Fakharian, Mohammad Varahram, Hamidreza Jamaati, Alireza Zali, Ali Akbar Velayati |
| 12 |
[GO] |
2022―Mar―26 |
Review on Approved and Inprogress COVID-19 Vaccines |
Amir Farnudian-Habibi, Mobina Mirjani, Vahideh Montazer, Shima Aliebrahimi, Iman Katouzian, Saeed Abdolhosseini, et al. (+4) Ali Rahmani, Hossein Keyvani, Seyed Nasser Ostad, Mazda Rad-Malekshahi |
|
